Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial
The Lancet - United Kingdom
doi 10.1016/s0140-6736(15)00590-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2015
Authors
Publisher
Elsevier BV